GlassScriptPhysician profile
Kaiwen Lin
NPI 1346488525
$2,223.52
in general payments reported to CMS, 2019-2025
11 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.90 · 2020: $199 · 2021: $1,025 · 2022: $40.21 · 2023: $588 · 2024: $122 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $350 · Consulting Fee: $300 · Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $350.00 |
| Consulting Fee | $300.00 |
| Food and Beverage | $265.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $660.28 | 2019-2025 | Tysabri |
| Abbvie INC. | $527.00 | 2023-2025 | |
| Genzyme Corporation | $350.00 | 2021 | |
| Amgen INC. | $189.40 | 2021-2022 | |
| Celgene Corporation | $143.09 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $105.06 | 2020 | |
| Novartis Pharmaceuticals Corporation | $92.72 | 2021 | |
| Impel Pharmaceuticals INC. | $72.61 | 2023 | Trudhesa |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $29.14 | 2019-2023 | Ajovy |
| Sk Life Science, INC. | $24.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaiwen Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.